|
Aprepitant (trade name: Emend™) occurs as medication, that is used in the treatment of chemotherapy induced nausea / emesis.
These are the neurokinin 1 receptor antagonist, that blocks a outcome of substance P. It mediates its burden via neurokinin Single receptor that is an endogenous receptor for substance P.
This class of doses come known as substance P antagonists (SPA).
|